Literature DB >> 17503471

Prostate stem cell antigen (PSCA) mRNA expression in prostatic intraepithelial neoplasia: implications for the development of prostate cancer.

Zhao Zhigang1, Shen Wenlu.   

Abstract

BACKGROUND: Prior data clearly demonstrated the expression of prostate stem cell antigen (PSCA) mRNA in prostatic intraepithelial neoplasia (PIN) tissues. The purpose of the present investigation was to determine whether PSCA mRNA expression was associated with the presence of cancer in this disease.
METHODS: One hundred seventeen men were diagnosed with isolated PIN on initial prostate biopsy, 51 with low-grade form (LGPIN), and 66 with high-grade form (HGPIN). PSCA mRNA expression in initial PIN and subsequent cancer was examined by in situ hybridization (ISH). The differences of the PSCA mRNA expression level between the groups were analyzed by the Chi-square and Student's t-test. Univariate and multivariate logistic regression analyses were performed to evaluate the predictive performance of PSCA mRNA.
RESULTS: PSCA mRNA expression level in 34 subsequent cancers was statistically increased compared with their paired PIN (P < 0.001), with a Gleason's dependence. HGPIN showed statistically high PSCA mRNA expression compared with LGPIN (P < 0.01). PSCA mRNA expression levels were significantly stronger in the initial isolated LGPIN and isolated HGPIN with subsequent cancer than those without (P < 0.001 and P < 0.001, respectively). Multivariate logistic regression analysis demonstrated that only PSCA mRNA was predictive of the onset of subsequent cancer in patients with isolated LGPIN and in those with isolated HGPIN, respectively.
CONCLUSIONS: Our data identify PSCA mRNA in initial PIN as a significant predictor of subsequent cancer, suggesting that PSCA implies in prostatic tumorigenesis and may be used to identify the patients with isolated PIN who are at high risk for cancer onset in the disease process. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503471     DOI: 10.1002/pros.20610

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  7 in total

Review 1.  Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide data.

Authors:  Thomas A Dunn; Helen L Fedor; Angelo M De Marzo; Jun Luo
Journal:  Asian J Androl       Date:  2012-02-06       Impact factor: 3.285

Review 2.  Prostate stem cell antigen: a Jekyll and Hyde molecule?

Authors:  Norihisa Saeki; Jian Gu; Teruhiko Yoshida; Xifeng Wu
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

3.  Bioengineered viral vectors for targeting and killing prostate cancer cells.

Authors:  Kai-xin Zhang; William Jia; Paul S Rennie
Journal:  Bioeng Bugs       Date:  2010-01-04

Review 4.  Oncolytic virotherapy for urological cancers.

Authors:  Zahid Delwar; Kaixin Zhang; Paul S Rennie; William Jia
Journal:  Nat Rev Urol       Date:  2016-05-24       Impact factor: 14.432

5.  Positive and negative regulation of prostate stem cell antigen expression by Yin Yang 1 in prostate epithelial cell lines.

Authors:  Shuai Tang; Meenu Mishra; Donna P Frazier; Miranda L Moore; Kazushi Inoue; Rajendar Deora; Guangchao Sui; Purnima Dubey
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

6.  Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.

Authors:  Claudia Kessler; Alessa Pardo; Mehmet K Tur; Stefan Gattenlöhner; Rainer Fischer; Katharina Kolberg; Stefan Barth
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-30       Impact factor: 4.322

Review 7.  Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expression.

Authors:  Vaishali Kashyap; Benjamin Bonavida
Journal:  Genes Cancer       Date:  2014-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.